ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jong D. Kim
Vaughn A. Starnes
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. D.
Right arrow Articles by Barr, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. D.
Right arrow Articles by Barr, M. L.

Ann Thorac Surg 2000;70:423-428
© 2000 The Society of Thoracic Surgeons


Original articles: general thoracic

Platelet activating factor acetylhydrolase decreases lung reperfusion injury

Jong D. Kim, MDa, Craig J. Baker, MDa, Randall F. Roberts, MDa, Sevak H. Darbinian, MDa, Keith A. Marcus, MSa, Suzanne M. Quardt, MDa, Vaughn A. Starnes, MDa, Mark L. Barr, MDa

a Department of Cardiothoracic Surgery, University of Southern California and Childrens Hospital Los Angeles, Los Angeles, California, USA

Address reprint requests to Dr Barr, Department of Cardiothoracic Surgery, University of Southern California, 1510 San Pablo St, Suite 415, Los Angeles, CA 90033
e-mail: mbarr{at}surgery.usc.edu

Background. Ischemia-reperfusion injury involves free radical production, polymorphonuclear neutrophil chemotaxis/degranulation, and production of proteolytic enzymes, complement components, coagulation factors, and cytokines. Activated polymorphonuclear neutrophils, endothelial cells, and macrophages produce platelet activating factor, which further promotes these inflammatory reactions. The recently cloned plasma form of platelet activating factor-acetylhydrolase (PAF-AH) demonstrates antiinflammatory effects by degrading platelet activating factor. We evaluated the effects of PAF-AH in an isolated perfused rat lung model by adding it to the flush solutions or to the reperfusion blood.

Methods. Rat lungs were isolated, flushed with Euro-Collins (EC) or University of Wisconsin (UW) solution, stored at 4°C for 6 or 12 hours, and reperfused using a cross-circulating syngeneic support rat. During reperfusion, oxygenation, compliance, and capillary filtration coefficient were calculated. There were four groups in the study; group I (control) had no PAF-AH added, group II had PAF-AH added to the flush solution, group III had PAF-AH added to reperfusion blood, and group IV had PAF-AH added to both flush solution and reperfusion blood.

Results. After 6 hours of storage, oxygenation, compliance, and capillary filtration coefficient significantly improved for EC in group IV. For UW, oxygenation improved in group IV whereas compliance improved in groups II, III, and IV. After 12 hours of storage, compliance improved for EC in group IV and capillary filtration coefficient improved in groups III and IV. For UW, oxygenation and compliance improved in groups II and IV, whereas capillary filtration coefficient improved in group IV.

Conclusions. Addition of PAF-AH to intracellular organ preservation solutions and to the blood reperfusate significantly improves postreperfusion oxygenation and compliance, and reduces lung capillary permeability.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
I. Inci, W. Zhai, S. Arni, S. Hillinger, P. Vogt, and W. Weder
N-Acetylcysteine Attenuates Lung Ischemia-Reperfusion Injury After Lung Transplantation
Ann. Thorac. Surg., July 1, 2007; 84(1): 240 - 246.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Umemura, I. Kato, Y. Hirashima, Y. Ishii, T. Inoue, J. Aoki, N. Kono, T. Oya, N. Hayashi, H. Hamada, et al.
Neuroprotective Role of Transgenic PAF-Acetylhydrolase II in Mouse Models of Focal Cerebral Ischemia
Stroke, March 1, 2007; 38(3): 1063 - 1068.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. O. Ibe, A. Ameer, A. M. Portugal, L. Renteria, and J. U. Raj
Platelet-Activating Factor Modulates Activity of Cyclic Nucleotides in Fetal Ovine Pulmonary Vascular Smooth Muscle
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 728 - 737.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. A. B. Reyes, T. Shimoyama, H. Akamatsu, and M. Sunamori
MCI-186 (edaravone), a free radical scavenger, attenuates ischemia-reperfusion injury and activation of phospholipase A2 in an isolated rat lung model after 18 h of cold preservation
Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 304 - 311.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee
Ischemia-Reperfusion-induced Lung Injury
Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. de Perrot and S. Keshavjee
Lung preservation
Ann. Thorac. Surg., August 1, 2002; 74(2): 629 - 631.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
I. Inci, D. Inci, A. Dutly, A. Boehler, and W. Weder
Melatonin attenuates posttransplant lung ischemia-reperfusion injury
Ann. Thorac. Surg., January 1, 2002; 73(1): 220 - 225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.